Additionally, there has been extensive data, particularly in breast cancer research, demonstrating crosstalk between estrogen signaling and ErbB2/HER2/neu, a membrane tyrosine kinase epidermal growth factor receptor, regulating MAPK and AKT signaling [85]. This evidence concerns the gene EGFR and breast carcinoma.